Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients

Rebecca Epperly, Brandon M. Triplett, Ying Li et al.|Transplantation and Cellular Therapy|2022

Cited by 3